Medicus Pharma (Medicus Pharma) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma COGS-to-Revenue?

Medicus Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was $0.00 Mil.

Medicus Pharma's COGS to Revenue for the three months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medicus Pharma's Gross Margin % for the three months ended in Dec. 2023 was N/A%.

Medicus Pharma COGS-to-Revenue Historical Data

The historical data trend for Medicus Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma COGS-to-Revenue Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

COGS-to-Revenue

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Medicus Pharma COGS-to-Revenue Calculation

Medicus Pharma's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Medicus Pharma's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Medicus Pharma (OTCPK:MDPLF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medicus Pharma's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medicus Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023